Effective treatment of choreaballism due to an

hereditary hypoparathyroidism lactic acidosis mitochondrial movement disorder mtDNA multisystem disease

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 07 05 2023
revised: 03 06 2023
accepted: 07 06 2023
medline: 23 6 2023
pubmed: 23 6 2023
entrez: 23 6 2023
Statut: epublish

Résumé

Hypokinetic and hyperkinetic movement disorders are a common phenotypic feature of mitochondrial disorders. Choreaballism has been reported particularly in patients with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome and in maternally inherited diabetes and deafness syndrome. The pathophysiological basis of movement disorders in mitochondrial disorders is the involvement of the basal ganglia or the midbrain. Haloperidol and mitochondrial cocktails have proven beneficial in some of these cases. Here we present another patient with mitochondrial choreaballism who benefited significantly from symptomatic therapy. The patient is a 14-year-old male with a history of hypoacusis, ptosis, and focal tonic-clonic seizures of the upper/lower limbs on either side since childhood. Since this time he has also developed occasional, abnormal involuntary limb movements, choreaballism, facial grimacing, carpopedal spasms, and abnormal lip sensations. He was diagnosed with a non-syndromic mitochondrial disorder after detection of the variant m.15043G > A in

Identifiants

pubmed: 37351357
doi: 10.1002/ccr3.7592
pii: CCR37592
pmc: PMC10282112
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e7592

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors have no conflict of interest to declare.

Références

Mol Genet Genomic Med. 2019 Mar;7(3):e541
pubmed: 30623604
Neurol Sci. 2020 Jun;41(6):1623-1625
pubmed: 31938984
PLoS One. 2009;4(3):e4913
pubmed: 19290059
Acta Neurochir (Wien). 2018 Feb;160(2):393-395
pubmed: 29248962
Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):524-529
pubmed: 27476418
Neurol Sci. 2021 Nov;42(11):4447-4457
pubmed: 34471947
J Neurol Sci. 2020 Oct 15;417:116947
pubmed: 32507345
Acta Diabetol. 2017 Aug;54(8):795-797
pubmed: 28361170
J Med Case Rep. 2019 Mar 6;13(1):63
pubmed: 30837005
Expert Opin Pharmacother. 2021 Jun;22(8):1015-1024
pubmed: 33550875
Pediatr Endocrinol Rev. 2018 Sep;16(1):203-208
pubmed: 30371039
Mov Disord. 2004 Oct;19(10):1256-8
pubmed: 15389992
Oral Dis. 2014 Jul;20(5):490-8
pubmed: 23902412
J Clin Med. 2021 May 12;10(10):
pubmed: 34065803
Rinsho Shinkeigaku. 2005 Jul;45(7):502-5
pubmed: 16119832
Am J Med Genet A. 2012 Dec;158A(12):3168-73
pubmed: 23169673
Cancer Inform. 2015 Jan 27;14(Suppl 1):1-9
pubmed: 25657573
J Neurol Sci. 2020 Oct 15;417:116950
pubmed: 32522371
Psychiatry Clin Neurosci. 2005 Aug;59(4):497-503
pubmed: 16048457
JAMA Neurol. 2016 Oct 1;73(10):1253-1254
pubmed: 27479845
J Neurol. 2022 Mar;269(3):1413-1421
pubmed: 34259909
J Neurol. 2020 Mar;267(3):823-829
pubmed: 31776719
ISRN Cardiol. 2012;2012:251723
pubmed: 22811935
Zhonghua Er Ke Za Zhi. 2013 Dec;51(12):909-14
pubmed: 24495761
Drugs. 2018 Apr;78(5):525-541
pubmed: 29484607
Neurology. 2007 Jan 2;68(1):56-8
pubmed: 17200493
Expert Rev Neurother. 2021 Aug;21(8):913-922
pubmed: 34353207
Ann Indian Acad Neurol. 2019 Oct-Dec;22(4):496-499
pubmed: 31736581

Auteurs

Josef Finsterer (J)

Neurology & Neurophysiology Center Vienna Austria.

Ritwik Ghosh (R)

Department of General Medicine Burdwan Medical College & Hospital Burdwan West Bengal India.

Classifications MeSH